Purchase Order 75N95020P00140
Award Date 3/24/20
Potential Completion Date 5/6/20
Potential Value $49K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Frederick, MD 21703, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This $16,260.00 firm-fixed-price purchase order was awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency, to Cyprotex US LLC, a foreign-owned for-profit contract research organization. The contract is for COVID-19/coronavirus-related services, including method development for liquid chromatography-mass spectrometry (LC-MS/MS) analysis of 1 compound, and uptake transporter screening/identification for 2 concentrations and 2 time points using a...
- This is a $37,000.00 firm fixed price purchase order contract awarded by the National Center for Advancing Translational Sciences, part of the U.S. Department of Health and Human Services, to Southern Research Institute, a non-profit research organization, for compound testing and cytotoxicity screening related to SARS-CoV-2. The contract does not have a set-aside designation. Through past federal contracts and grants, Southern Research has provided a range of research and development services...
- This firm-fixed-price purchase order contract was awarded by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to the Southern Research Institute, a non-profit research organization. The $42,000 contract is for COVID-19 compound testing and cytotoxicity screening in the SARS-CoV-2 CPE assay. This work supports NCATS' mission of advancing the translation of medical discoveries into clinical applications. The contract has no...
- This federal contract award, valued at $79,000.00, was issued by the National Center for Advancing Translational Sciences (NCATS), a civilian agency, to the Southern Research Institute, a non-profit organization, for "HIGH-THROUGHPUT SARS-COV-2 ALPHALISA SCREENING FOR COVID-19 DRUG DISCOVERY - ANTIVIRAL INITIATIVE". The contract has a firm fixed price and was awarded on a non-competitive basis with no set-aside designation. Based on the agency and description, this contract supports...
- This federal contract award for $25,100.00 was issued by the National Center for Advancing Translational Sciences (NCATS), a part of the U.S. Department of Health and Human Services, to 10X Genomics, Inc. The contract is for a Chromium Controller & Next GEM Accessory Kit to support the NCATS' SARS-CoV-2 project, specifically to characterize single-cell response in a 3D lung model. The contract is a firm-fixed price purchase order with a period of performance through February 17, 2021. It was...
- The U.S. National Center for Advancing Translational Sciences (NCATS) awarded a $62,000 firm-fixed-price purchase order to Revvity Health Sciences, Inc. for the delivery of COVID-19 high throughput homogeneous assays for the detection of SARS-CoV-2 proteins in 384-well plates. This award, which did not utilize a set-aside, was made on April 15, 2020 with a completion date of October 31, 2020 under the Coronavirus COVID-19 national interest action. Revvity Health Sciences, Inc. is a subsidiary of...
- This $136,000 firm fixed price purchase order was awarded by the National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) to Southern Research Institute, a non-profit research organization, to screen assay-ready plates in a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nanoluc reporter virus (NLRV) assay. The contract supports the Antiviral Program for Pandemics (APP) initiative to develop treatments for SARS-CoV-2 and other coronaviruses,...
- This federal contract award, with an ID of 75N93024P01130, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to The Trustees of Columbia University in the City of New York, doing business as the Health Sciences Division. The contract, which is a firm fixed-price purchase order, is for TBDC CAPSEQ-TRANCRIPTOME ANALYSIS SERVICE and has a ceiling value of $41,250.00. The contract does not have a set-aside designation, indicating open competition....
- This is a $37,000 firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to Southern Research Institute. The contract is for COVID-19 compound testing and cytotoxicity screening in the SARS-CoV-2 CPE assay. This non-competitive award was made under simplified acquisition procedures, with the vendor selected due to prior work on the compound testing. The period of performance runs through...
- This firm-fixed-price purchase order contract, valued at $47,000.00, was awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency, to Southern Research Institute, a non-profit organization, for COVID-19 compound dose response testing. The contract has no set-aside designation and is part of NCATS' efforts to evaluate potential COVID-19 treatments. Southern Research Institute has a history of providing drug discovery, development, and testing services to...